University of California Davis Cancer Center UC Davis Cancer (3) — Sacramento, California

University of California Davis Cancer Center UC Davis Cancer (3) is a clinical research site located in Sacramento, California, United States 95817.

Crixeo Health Trust Score: 64/100 (FAIR). This profile has not yet been claimed by the site owner.

University of California Davis Cancer Center UC Davis Cancer (3) has participated in 4 clinical trials.

Therapeutic areas: PTCH1 or SMO Activated Solid and Hematologic Tumors, Tumors With CDK4/6 Pathway Activation, Brain Metastasis.

Sponsors: Novartis Pharmaceuticals, Pfizer.

Sponsor Feasibility Report

Trust Score: 64/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of California Davis Cancer Center UC Davis Cancer (3)?

University of California Davis Cancer Center UC Davis Cancer (3) has a Crixeo Trust Score of 64/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of California Davis Cancer Center UC Davis Cancer (3) conducted?

University of California Davis Cancer Center UC Davis Cancer (3) has 4 clinical trials on record. Their work covers PTCH1 or SMO Activated Solid and Hematologic Tumors, Tumors With CDK4/6 Pathway Activation, Brain Metastasis.

Is University of California Davis Cancer Center UC Davis Cancer (3) accredited by Crixeo Health?

University of California Davis Cancer Center UC Davis Cancer (3) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of California Davis Cancer Center UC Davis Cancer (3)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.